These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

97 related articles for article (PubMed ID: 509846)

  • 21. A new imaging agent for medullary carcinoma of the thyroid.
    Ohta H; Yamamoto K; Endo K; Mori T; Hamanaka D; Shimazu A; Ikekubo K; Makimoto K; Iida Y; Konishi J
    J Nucl Med; 1984 Mar; 25(3):323-5. PubMed ID: 6321700
    [TBL] [Abstract][Full Text] [Related]  

  • 22. (99m)Tc HYNIC-TOC imaging and 177Lu DOTA-octreotate treatment in non-iodine-concentrating dedifferentiated thyroid carcinoma metastases: an unusual alternative diagnosis.
    Basu S; Joshi A
    Clin Nucl Med; 2014 Jul; 39(7):632-4. PubMed ID: 24873792
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Scintigraphy of medullary carcinoma of the thyroid by new radiopharmaceuticals].
    Tada J; Konishi J; Torizuka K; Makimoto K; Miyauchi A
    Rinsho Hoshasen; 1984 Sep; 29(9):1043-4. PubMed ID: 6096600
    [No Abstract]   [Full Text] [Related]  

  • 24. Technetium-99m-sestamibi uptake by recurrent Hurthle cell carcinoma of the thyroid.
    Balon HR; Fink-BennetT D; Stoffer SS
    J Nucl Med; 1992 Jul; 33(7):1393-5. PubMed ID: 1535374
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Metastatic medullary thyroid cancer: localization with iodine-131 metaiodobenzylguanidine.
    Sone T; Fukunaga M; Otsuka N; Morita R; Muranaka A; Yanagimoto S; Tomomitsu T; Nakayama H; Harada T
    J Nucl Med; 1985 Jun; 26(6):604-8. PubMed ID: 3158726
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Thyroid cancer with a high 123I-NaI uptake in primary and metastatic foci with euthyroidism.
    Nakayama C; Nakata H; Zeze F; Eto S; Ichiya Y
    Eur J Nucl Med; 1987; 13(9):480-1. PubMed ID: 3440474
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Comparative radionuclide imaging of metastatic insular carcinoma of the thyroid: value of technetium-99m-(V)DMSA.
    Yen TC; King KL; Yang AH; Liu RS; Yeh SH
    J Nucl Med; 1996 Jan; 37(1):78-80. PubMed ID: 8544007
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Hyperthyroidism with metastatic follicular thyroid carcinoma.
    Chapman CN; Sziklas JJ; Spencer RP; Bower BF; Rosenberg RJ
    J Nucl Med; 1984 Apr; 25(4):466-8. PubMed ID: 6152721
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Paradoxical changes in iodine-131 scintigraphic findings in advanced follicular thyroid cancer.
    Krishna L; Dadparvar S; Brady LW; Micaily B; Meihofer M; Slizofski WJ; Brown SJ; Chevres A; Roman R; Khan AS
    J Nucl Med; 1993 Sep; 34(9):1574-6. PubMed ID: 8355078
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Early and delayed imaging of Tc-99m HMPAO versus Tl-201 in benign and malignant thyroid tumors. Similar uptake but different retention.
    Ohnishi T; Noguchi S; Murakami N; Harao M; Jinnouchi S; Hoshi H; Futami S; Nagamachi S; Watanabe K
    Clin Nucl Med; 1992 Oct; 17(10):806-11. PubMed ID: 1424358
    [TBL] [Abstract][Full Text] [Related]  

  • 31. The use of non-specific tracers in the follow up of differentiated thyroid cancer: results with Tc-99m tetrofosmin whole body scintigraphy.
    Lind P; Gallowitsch HJ
    Acta Med Austriaca; 1996; 23(1-2):69-75. PubMed ID: 8767519
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Comparison of technetium-99m and iodine-123 nodules: correlation with pathologic findings.
    Beierwaltes WH
    J Nucl Med; 1990 Apr; 31(4):400-2. PubMed ID: 2157830
    [No Abstract]   [Full Text] [Related]  

  • 33. Aggressive poorly differentiated adenocarcinoma of the lung diagnosed 13 months after initial diagnosis of papillary thyroid carcinoma with "non-iodine concentrating" pulmonary metastasis.
    Basu S; Rekhi B; Shamim SA; Jambhekar NA
    Hell J Nucl Med; 2012; 15(3):252-3. PubMed ID: 23227462
    [No Abstract]   [Full Text] [Related]  

  • 34. Postoperative uptake in the thyroid bed, not tumor stage, determines the usefulness of diagnostic whole body scan in the first year after ablation with radioiodine.
    Rosário PW; Barroso AL; Purisch S
    Thyroid; 2007 Aug; 17(8):803-4. PubMed ID: 17708716
    [No Abstract]   [Full Text] [Related]  

  • 35. Radionuclide imaging in medullary thyroid carcinoma: evaluation of two new radiopharmaceuticals.
    Clarke SE; Lazarus CR; Maisey MN
    Henry Ford Hosp Med J; 1987; 35(2-3):124-6. PubMed ID: 2826368
    [No Abstract]   [Full Text] [Related]  

  • 36. Thyroid imaging agents: a comparison of I-123 and Tc-99m pertechnetate.
    Ryo UY; Vaidya PV; Schneider AB; Bekerman C; Pinsky SM
    Radiology; 1983 Sep; 148(3):819-22. PubMed ID: 6308711
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Radioisotope imaging for the evaluation of thyroid neoplasia and hypothyroidism in a dog.
    Branam JE; Leighton RL; Hornof WJ
    J Am Vet Med Assoc; 1982 May; 180(9):1077-9. PubMed ID: 6282795
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Comparison of technetium-99m and iodine-123 imaging of thyroid nodules: correlation with pathologic findings.
    Kusić Z; Becker DV; Saenger EL; Paras P; Gartside P; Wessler T; Spaventi S
    J Nucl Med; 1990 Apr; 31(4):393-9. PubMed ID: 2157829
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Disparate thyroid imaging with 99mTc pertechnetate and radioiodine (author's transl)].
    Koppers B
    Rofo; 1981 Dec; 135(6):717-20. PubMed ID: 6284606
    [No Abstract]   [Full Text] [Related]  

  • 40. Cold technetium-99m HDP and hot gallium-67 images of metastatic adenocarcinoma of bone.
    Ahn CS; Tow DE
    Clin Nucl Med; 1988 May; 13(5):371-2. PubMed ID: 3390986
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.